Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe short answer: fasting while taking Wegovy is not prohibited, but it is rarely necessary and may not be helpful. Wegovy (semaglutide) already suppresses appetite substantially, so for most people the question resolves itself — eating less happens naturally. That said, some people on Wegovy actively wonder whether adding a fasting window could accelerate results or whether it could cause problems. These are sensible things to think through, and this page works through the decision. Wegovy is a prescription-only medicine; a GPhC-registered prescriber assesses whether it is suitable for you before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy works by activating GLP-1 receptors in the brain and gut, slowing gastric emptying and dialling down hunger signals. In the STEP 1 trial, published in the New England Journal of Medicine, participants on 2.4mg semaglutide lost an average of around 15% of body weight over 68 weeks. That reduction happened without fasting protocols, it happened because people ate less, consistently, because they were less hungry.
This matters for the fasting decision because most fasting strategies work through the same mechanism: reduced calorie intake. If Wegovy is already doing that job, adding a strict eating window may not add much. Some people find the structure of time-restricted eating helpful alongside Wegovy, a clear start and stop to the eating day can simplify decisions when appetite is unpredictable. That is a legitimate reason to try it. But the expectation that fasting will dramatically amplify Wegovy's results is not well supported.
There is also a practical reality worth naming. On Wegovy, particularly in the early weeks at lower doses, appetite can fluctuate. On some days you will barely want to eat. On others it returns closer to normal. Locking yourself into a narrow eating window on a low-hunger day can mean eating almost nothing, and that is where the nutritional risk begins. Pages on eating habits that work well on Wegovy go into more detail on managing intake day to day.
GLP-1 medicines reduce body weight, but not all of that reduction is fat. Studies in this area consistently show that without adequate protein and resistance activity, a meaningful proportion of the weight lost can be lean muscle mass. This is not unique to Wegovy (it happens with calorie restriction generally) but it is worth taking seriously because muscle is metabolically active tissue and losing it can make weight regain easier later.
Fasting compounds this risk if the eating window becomes too short or the total daily protein intake falls below what the body needs. UK dietary guidance suggests roughly 0.75g of protein per kilogram of body weight as a general baseline; many clinicians working in this area recommend more during active weight loss. If your eating window is six hours and your appetite is suppressed, hitting those targets takes deliberate effort.
This is one reason our prescribers at nume take nutrition seriously as part of the clinical conversation. It is also why the advice to combine Wegovy with a reduced-calorie diet (as stated in the licensed indication) does not mean aggressive calorie restriction. A useful starting point for thinking about what to eat on Wegovy is protein adequacy first, then overall calories.
Nausea is the most commonly reported side effect on Wegovy, particularly after dose increases. The NHS medicines page for semaglutide lists nausea, vomiting, diarrhoea and constipation among the most frequent effects, typically most noticeable in the first few days after each new dose. Skipping meals during this period tends to make nausea worse, not better. An empty stomach can amplify GI discomfort with GLP-1 medicines, small, plain, easy meals often settle symptoms more reliably than waiting them out.
If you are someone who finds nausea is a persistent issue, fasting is probably worth setting aside for now. The goal in the early months is finding a dose that is both effective and tolerable. Adding the stress of a fasting window creates an unnecessary variable. On the other hand, if you are established on Wegovy, tolerating it well, and you genuinely prefer eating in a defined window (say, between noon and 8pm) there is no clinical reason that has to stop. The question is whether the window is wide enough to get adequate nutrition in, particularly protein.
Some people ask about combining intermittent fasting with Wegovy more formally, with specific protocols. That page covers the evidence and practicalities in more depth. There is also a separate look at how fatty foods interact with Wegovy if meal composition rather than timing is the question.
The decision about whether to fast on Wegovy is genuinely individual. A few things are worth being honest with yourself about. Are you drawn to fasting because you have found it useful before and you are curious whether it complements Wegovy? That is different from fasting because you feel you should be doing more to make the medicine work. Wegovy is doing the heavy lifting; your job is to eat well within whatever appetite presents itself.
If you are thinking about reducing how often you eat while on treatment, it is worth raising with the prescriber who manages your Wegovy. They can review your progress, check that your nutrition approach is supporting rather than fighting the medicine, and flag if anything in your pattern looks like it needs adjusting. That clinical check-in is part of what responsible Wegovy treatment looks like, details on the specifics of fasting while on Wegovy are worth reading before you start.
For people considering starting Wegovy and wondering how lifestyle changes fit in, the weight-loss treatment overview lays out how the clinical process works. Nutrition, activity and the medicine itself are reviewed together, not in isolation. And for anything about what people actually eat on Wegovy day to day, that page reflects the practical reality rather than the theory.
Wegovy is a prescription-only medicine. If you would like a clinical assessment to see whether it is appropriate for you, you can start your free consultation with our prescribers today.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.